$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2017 Q3 Form 10-K Financial Statement

#000156459017024834 Filed on December 12, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2017 Q1
Revenue $8.714M $9.342M $8.986M
YoY Change 27784.11% 23502.3% 20439.27%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.530M $6.990M $6.950M
YoY Change -27.36% -23.52% -33.68%
% of Gross Profit
Research & Development $8.280M $6.910M $11.44M
YoY Change -29.05% -26.67% 14.15%
% of Gross Profit
Depreciation & Amortization $1.200M $1.100M $1.200M
YoY Change 33.33% 37.5% 50.0%
% of Gross Profit
Operating Expenses $18.96M $15.06M $15.12M
YoY Change -4.15% 59.78% -29.06%
Operating Profit -$10.25M -$5.714M -$6.130M
YoY Change -52.97% -70.46% -71.17%
Interest Expense -$480.0K $131.4K $108.7K
YoY Change 0.0% 285.18% 37.55%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -97.77%
Pretax Income -$10.73M -$5.520M -$6.040M
YoY Change -51.71% -71.58% -70.98%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.73M -$5.520M -$6.043M
YoY Change -51.71% -71.58% -70.97%
Net Earnings / Revenue -123.16% -59.08% -67.24%
Basic Earnings Per Share
Diluted Earnings Per Share -$143.5K -$73.83K -$80.93K
COMMON SHARES
Basic Shares Outstanding 74.57M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2017 Q2 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.60M $75.10M $86.60M
YoY Change -23.19% 68.39% 40.81%
Cash & Equivalents $24.84M $38.38M $61.72M
Short-Term Investments $40.80M $36.80M $24.90M
Other Short-Term Assets $1.360M $1.800M $2.400M
YoY Change -63.95% -63.27% -48.94%
Inventory
Prepaid Expenses $867.4K
Receivables $67.80K $900.0K $600.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $67.90M $77.90M $89.70M
YoY Change -24.97% 57.06% 35.7%
LONG-TERM ASSETS
Property, Plant & Equipment $15.51M $16.10M $15.70M
YoY Change 0.73% 30.89% 256.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $141.9K $200.0K $200.0K
YoY Change 16.01% 63.49% 100.0%
Total Long-Term Assets $36.12M $37.20M $37.20M
YoY Change -4.19% 3.52% 30.53%
TOTAL ASSETS
Total Short-Term Assets $67.90M $77.90M $89.70M
Total Long-Term Assets $36.12M $37.20M $37.20M
Total Assets $104.0M $115.1M $126.9M
YoY Change -18.86% 34.57% 34.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.077M $3.200M $2.600M
YoY Change -66.59% -46.18% -65.33%
Accrued Expenses $4.565M $3.000M $3.000M
YoY Change -46.92% -52.1% -42.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K $200.0K
YoY Change 0.0% -50.0% 0.0%
Total Short-Term Liabilities $18.70M $20.30M $27.60M
YoY Change -27.07% 36.79% 95.74%
LONG-TERM LIABILITIES
Long-Term Debt $2.300M $2.400M $2.400M
YoY Change -8.0% -20.0% 500.0%
Other Long-Term Liabilities $2.100M $2.800M $3.600M
YoY Change 950.0% -66.27% -41.94%
Total Long-Term Liabilities $4.400M $5.200M $6.000M
YoY Change -41.4% -53.98% -9.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.70M $20.30M $27.60M
Total Long-Term Liabilities $4.400M $5.200M $6.000M
Total Liabilities $22.60M $25.00M $33.00M
YoY Change -31.83% -2.34% 64.18%
SHAREHOLDERS EQUITY
Retained Earnings -$432.8M
YoY Change 8.63%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $81.42M $90.10M $93.90M
YoY Change
Total Liabilities & Shareholders Equity $104.0M $115.1M $126.9M
YoY Change -18.84% 34.62% 34.14%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2017 Q1
OPERATING ACTIVITIES
Net Income -$10.73M -$5.520M -$6.043M
YoY Change -51.71% -71.58% -70.97%
Depreciation, Depletion And Amortization $1.200M $1.100M $1.200M
YoY Change 33.33% 37.5% 50.0%
Cash From Operating Activities -$9.200M -$10.40M -$14.30M
YoY Change -9.8% -43.17% -3.38%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$1.100M -$1.400M
YoY Change -96.43% 83.33% 1300.0%
Acquisitions
YoY Change
Other Investing Activities -$4.100M -$11.80M -$24.80M
YoY Change -510.0% -216.83% -875.0%
Cash From Investing Activities -$4.200M -$12.90M -$26.20M
YoY Change 133.33% -235.79% -945.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K 0.000 200.0K
YoY Change -100.19% -100.0% -200.0%
NET CHANGE
Cash From Operating Activities -9.200M -10.40M -14.30M
Cash From Investing Activities -4.200M -12.90M -26.20M
Cash From Financing Activities -100.0K 0.000 200.0K
Net Change In Cash -13.50M -23.30M -40.30M
YoY Change -132.45% 253.03% 238.66%
FREE CASH FLOW
Cash From Operating Activities -$9.200M -$10.40M -$14.30M
Capital Expenditures -$100.0K -$1.100M -$1.400M
Free Cash Flow -$9.100M -$9.300M -$12.90M
YoY Change 22.97% -47.46% -12.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20464439
CY2016Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
442915
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
165985255
CY2016Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
440580
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
11595816
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
10232897
CY2015 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1110524
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1020734
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3485421
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3509995
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2554802
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-401777
CY2017Q3 us-gaap Minority Interest
MinorityInterest
-555188
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80867162
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104022280
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q3 us-gaap Notes Payable Current
NotesPayableCurrent
194310
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
46407
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25643794
CY2017Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1929052
CY2016Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2500000
CY2017Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
2325018
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
33232
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-432815338
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
81422350
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22164868
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74785426
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74785426
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2618014
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-81720602
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61050880
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11595816
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-670765
CY2015 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
10142786
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2050817
CY2017 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
890362
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1312524
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
57352
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34377895
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73898598
CY2015 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
401876
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10232897
CY2015 arwr Exchange Rights Exercised During Period Value
ExchangeRightsExercisedDuringPeriodValue
3072
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109621634
CY2016 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3691398
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
133869
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7891595
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
271931
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-403261
CY2017 arwr Exchange Rights Exercised During Period Value
ExchangeRightsExercisedDuringPeriodValue
17150
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
7891595
CY2017 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
43519
CY2016 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-231902
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7203
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2814509
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
157981
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5000000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2497804
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-871833
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4435784
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-274752
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
131143
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-40385
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-23938972
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-64427486
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-65707615
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7918198
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3860237
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1970612
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
44974736
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4248716
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17308000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1714313
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1046571
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700429
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
500
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2017Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
55131817
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
290521
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-60527881
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4152094
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-51296256
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81214354
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132510610
CY2017 us-gaap Interest Paid
InterestPaid
187647
CY2016 us-gaap Interest Paid
InterestPaid
11287
CY2015 us-gaap Interest Paid
InterestPaid
14429
CY2016 arwr Property And Equipment Purchased Through Tenant Improvement Allowance Financing
PropertyAndEquipmentPurchasedThroughTenantImprovementAllowanceFinancing
4849360
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26090950
CY2015 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
10000000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-48644218
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
13447763
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
14120838
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
197790
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
217549
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
213991
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
438838
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
634187
CY2017 arwr Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
272818
CY2016 arwr Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
3752120
CY2015 arwr Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
504512
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12419119
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52231433
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12055309
CY2016 arwr Property And Equipment Expenditures Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentExpendituresIncludedInAccountsPayableAndAccruedExpenses
4801930
CY2017 arwr Proceeds From Refundable Income Tax Credits
ProceedsFromRefundableIncomeTaxCredits
3635016
CY2016 arwr Proceeds From Refundable Income Tax Credits
ProceedsFromRefundableIncomeTaxCredits
1365288
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several bank accounts at two financial institutions for its operations. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2016Q3 arwr Research Equipment
ResearchEquipment
7490400
CY2016Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
80841
CY2016Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
11885365
CY2017 arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
-19800000
CY2017 arwr Net Cash Provided By Used In Operating Activities Excluding Upfront Payment Received
NetCashProvidedByUsedInOperatingActivitiesExcludingUpfrontPaymentReceived
-53900000
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2017Q3 arwr Research Equipment
ResearchEquipment
9660960
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2017Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
600334
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19899521
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4512760
CY2017Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
132078
CY2017Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12208380
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22601752
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7088733
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700429
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11962294
CY2017 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2017-03-21
CY2017Q1 arwr Class Of Warrant Or Right Number Of Rights Distribution For Each Outstanding Share Common Stock
ClassOfWarrantOrRightNumberOfRightsDistributionForEachOutstandingShareCommonStock
1
CY2017 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2017-03-22
CY2017 arwr Rights Expiration Date
RightsExpirationDate
2018-03-21
CY2017Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
432284
CY2017 arwr Facility Rent Expense
FacilityRentExpense
1554000
CY2016 arwr Facility Rent Expense
FacilityRentExpense
926000
CY2015 arwr Facility Rent Expense
FacilityRentExpense
831000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1531234
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1435409
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1044431
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1070496
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1097168
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4669328
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10848066
CY2017Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
208506
CY2017Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
223820
CY2017Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
240258
CY2017Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
257903
CY2017Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
276845
CY2017Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
1326192
CY2017Q3 us-gaap Contractual Obligation
ContractualObligation
2533524
CY2017Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2017Q3 us-gaap Purchase Obligation
PurchaseObligation
11400000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
638000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1643927
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
135730
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5549543
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4065611
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.79
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each RSU will be exchanged for one share of the Company’s Common Stock. Restricted stock unit awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1337619
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1691050
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5670468
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0134
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0105
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0231
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0146
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0189
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.24
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7224958
CY2017Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
2196542
CY2016Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
2957528
CY2017Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
203477
CY2017Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
132119837
CY2016Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
125120957
CY2017Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
5358700
CY2016Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
5544091
CY2017Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1068206
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
865675
CY2017Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
1020162
CY2017Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
149840686
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
142538584
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
136625436
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
128695371
CY2017Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
13215250
CY2016Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
13804268
CY2016Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
38945
CY2017Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13215250
CY2016Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13843213
CY2017Q3 arwr Percentage Of Valuation Allowance
PercentageOfValuationAllowance
1.00
CY2016Q3 arwr Federal Net Operating Loss Carry Forward
FederalNetOperatingLossCarryForward
260700000
CY2017 arwr Federal Estimated Net Operating Loss Carry Forward
FederalEstimatedNetOperatingLossCarryForward
24500000
CY2016Q3 arwr State Net Operating Loss Carry Forwards
StateNetOperatingLossCarryForwards
398300000
CY2017 arwr State Estimated Net Operating Loss Carry Forward
StateEstimatedNetOperatingLossCarryForward
24200000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400
CY2017 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2400
CY2016 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2400
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.090
CY2017 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
0.058
CY2016 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
0.011
CY2017 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.009
CY2016 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
-0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.231
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.411
CY2017 arwr Effective Income Tax Rate Reconciliation True Up On Deferred Taxes
EffectiveIncomeTaxRateReconciliationTrueUpOnDeferredTaxes
-0.030
CY2017 arwr Effective Income Tax Rate Reconciliation State Blended Rate Change
EffectiveIncomeTaxRateReconciliationStateBlendedRateChange
-0.057
CY2017 arwr Effective Income Tax Rate Reconciliation Nondeductible Income Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleIncomeExpenseOther
-0.022
CY2016 arwr Effective Income Tax Rate Reconciliation Nondeductible Income Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleIncomeExpenseOther
-0.007
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
426470
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
476835
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
407603
CY2016Q4 us-gaap Revenues
Revenues
4365496
CY2017Q1 us-gaap Revenues
Revenues
8985930
CY2017Q2 us-gaap Revenues
Revenues
9342498
CY2017Q3 us-gaap Revenues
Revenues
8713785
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-14901887
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6129642
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5714164
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10250216
CY2016Q4 us-gaap Profit Loss
ProfitLoss
-12086108
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-6042557
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-5519741
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-10731889
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-12086108
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-6042557
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-5519741
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-10731889
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2015Q4 us-gaap Revenues
Revenues
43750
CY2016Q1 us-gaap Revenues
Revenues
43750
CY2016Q2 us-gaap Revenues
Revenues
39583
CY2016Q3 us-gaap Revenues
Revenues
31250
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-19341270
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-21264855
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19341487
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21795114
CY2015Q4 us-gaap Profit Loss
ProfitLoss
-19264414
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-20815860
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-19420743
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-22221985
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-19264414
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-20815860
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-19420743
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-22221985
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34

Files In Submission

Name View Source Status
0001564590-17-024834-index-headers.html Edgar Link pending
0001564590-17-024834-index.html Edgar Link pending
0001564590-17-024834.txt Edgar Link pending
0001564590-17-024834-xbrl.zip Edgar Link pending
arwr-10k_20170930.htm Edgar Link pending
arwr-20170930.xml Edgar Link completed
arwr-20170930.xsd Edgar Link pending
arwr-20170930_cal.xml Edgar Link unprocessable
arwr-20170930_def.xml Edgar Link unprocessable
arwr-20170930_lab.xml Edgar Link unprocessable
arwr-20170930_pre.xml Edgar Link unprocessable
arwr-ex211_172.htm Edgar Link pending
arwr-ex231_173.htm Edgar Link pending
arwr-ex311_12.htm Edgar Link pending
arwr-ex312_11.htm Edgar Link pending
arwr-ex321_8.htm Edgar Link pending
arwr-ex322_13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201712121801334011632.jpg Edgar Link pending
g201712121801334231633.jpg Edgar Link pending
g201712121801334281634.jpg Edgar Link pending
g201712121801334501635.jpg Edgar Link pending
g201712121801338451636.jpg Edgar Link pending
g201712121801369961637.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending